Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Body Computing” On The Web: An Interview With Cardiologist Leslie Saxon

This article was originally published in The Gray Sheet

Executive Summary

Leslie Saxon says the next big thing in medicine is "body computing.

You may also be interested in...



Industry Presents Scaled-Down Remote-Monitoring Legislation

AdvaMed has given the Senate Finance Committee a scaled-down version of legislation to promote remote-monitoring devices that it hopes will be included in a Medicare package being shaped in Congress this year

St. Jude Sees Future ICD Market Growth With New Treatment Paradigms

St. Jude Medical expects its next-generation Unity electronics platform for use in both implantable cardioverter defibrillators and pacemakers to impact two-thirds of all revenue going forward

Probiotics And Cold Remedies Boost Recordati In 2023

Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025435

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel